Found that the big players have increased their holdings in CRISPR again, despite the small gains, the fluctuations are as if nothing happened. Summit's technicals were so weak that I almost got stopped out, but luckily the directors chose to increase their holdings, hmm... who should I trust? iBio actually managed to exceed expectations with 100K in revenue, just surged through a medical conference, and now it's down 14% in a day, the obesity drug pipeline is all the talk, but I feel like what I'm holding is toast again. Enveric got halved right after a patent boost, the financing news dropped... I really don't want to look at it. The only decent BEAT, FDA approved the product and it went crazy, someone called for a target price adjustment to 5.50, my brain says don't chase but my hand can't help clicking in, it's so annoying, who doesn't want to buy a limit-up stock? 🤦‍♂️